---
figid: PMC4212018__nihms595549f1
figlink: /pmc/articles/PMC4212018/figure/F1/
number: F1
caption: '(Left) ERK1/2 pathway inhibition by vemurafenib leads to downregulation
  of DUSP and SPRY proteins. Loss of SPRY results in more efficient NRAS activation
  leading to a reactivation of the ERK1/2 pathway. This is enhanced by reduced ERK1/2
  dephosphorylation resulting from lower levels of DUSP proteins. (Middle) Vemurafenib
  treatment increases PDGFRβ and ERBB3 leading to activation of the AKT pathway and
  promoting resistance to ERK1/2 pathway inhibition. (Right) Increased levels of JARID1B
  and PGC1α following ERK1/2 pathway inhibition leads to a metabolic switch from glycolysis
  to oxidative phosphorylation promoting resistance to RAF inhibition. Abbreviations
  used are: EGFR, epidermal growth factor receptor; GRB2, growth factor receptor-bound
  protein 2; SOS, son of sevenless; NRAS, neuroblastoma RAS viral oncogene homolog;
  BRAF, v-Raf murine sarcoma viral oncogene homolog B1; CRAF, v-Raf-1 murine leukemia
  viral oncogene homolog 1; MEK, mitogen-activated protein kinase kinase; ERK, extracellular
  signal-regulated kinase; DUSP, dual-specificity phosphatase; SPRY, sprouty; PDGFRβ,
  platelet-derived growth factor receptor, beta polypeptide; ERBB3, v-erb-b2 avian
  erythroblastic leukemia viral oncogene homolog 3; ERBB2, v-erb-b2 avian erythroblastic
  leukemia viral oncogene homolog 2; PI-3K, phosphatidylinositol 3-kinase; AKT, v-akt
  murine thymoma viral oncogene; FOXD3, forkhead box transcription factor D3; JARID1B,
  lysine-specific demethylase 5B; MITF, microphthalmia-associated transcription factor;
  PGC1α, peroxisome proliferator-activated receptor gamma coactivator 1 alpha.'
pmcid: PMC4212018
papertitle: Adaptive resistance to RAF inhibitors in melanoma.
reftext: Curtis H. Kugel, et al. Pigment Cell Melanoma Res. ;27(6):1032-1038.
pmc_ranked_result_index: '123894'
pathway_score: 0.9670371
filename: nihms595549f1.jpg
figtitle: Adaptive resistance to RAF inhibitors in melanoma
year: ''
organisms:
- Mus musculus
- Diaporthe sclerotioides
- Homo sapiens
ndex: 475c772a-decf-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4212018__nihms595549f1.html
  '@type': Dataset
  description: '(Left) ERK1/2 pathway inhibition by vemurafenib leads to downregulation
    of DUSP and SPRY proteins. Loss of SPRY results in more efficient NRAS activation
    leading to a reactivation of the ERK1/2 pathway. This is enhanced by reduced ERK1/2
    dephosphorylation resulting from lower levels of DUSP proteins. (Middle) Vemurafenib
    treatment increases PDGFRβ and ERBB3 leading to activation of the AKT pathway
    and promoting resistance to ERK1/2 pathway inhibition. (Right) Increased levels
    of JARID1B and PGC1α following ERK1/2 pathway inhibition leads to a metabolic
    switch from glycolysis to oxidative phosphorylation promoting resistance to RAF
    inhibition. Abbreviations used are: EGFR, epidermal growth factor receptor; GRB2,
    growth factor receptor-bound protein 2; SOS, son of sevenless; NRAS, neuroblastoma
    RAS viral oncogene homolog; BRAF, v-Raf murine sarcoma viral oncogene homolog
    B1; CRAF, v-Raf-1 murine leukemia viral oncogene homolog 1; MEK, mitogen-activated
    protein kinase kinase; ERK, extracellular signal-regulated kinase; DUSP, dual-specificity
    phosphatase; SPRY, sprouty; PDGFRβ, platelet-derived growth factor receptor, beta
    polypeptide; ERBB3, v-erb-b2 avian erythroblastic leukemia viral oncogene homolog
    3; ERBB2, v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2; PI-3K,
    phosphatidylinositol 3-kinase; AKT, v-akt murine thymoma viral oncogene; FOXD3,
    forkhead box transcription factor D3; JARID1B, lysine-specific demethylase 5B;
    MITF, microphthalmia-associated transcription factor; PGC1α, peroxisome proliferator-activated
    receptor gamma coactivator 1 alpha.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - DUSP2
  - PIK3CD
  - AKT3
  - PIK3R3
  - SOS1
  - PDGFRB
  - MAPK3
  - MAPK1
  - GRB2
  - ARAF
  - RAF1
  - BRAF
  - NRAS
  - DUSP6
  - PPARGC1A
  - AKT1
  - AKT2
  - PIK3CB
  - PIK3CA
  - PIK3CG
  - MITF
  - DUSP3
  - DUSP4
  - DUSP5
  - SPRY3
  - SPRY1
  - EGFR
  - ERBB3
  - DUSP1
  - SPRY4
  - PIK3R4
  - MAP2K2
  - ERBB2
  - KDM5B
  - MAP2K1
  - SOS2
  - PIK3R6
  - PIK3R5
  - SPRY2
  - Cancer
  - Lung cancer
  - Noonan syndrome
genes:
- word: DUSP
  symbol: DUSP
  source: bioentities_symbol
  hgnc_symbol: DUSP2
  entrez: '1844'
- word: PI-3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI-3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: PDGFRB
  symbol: PDGFRB
  source: hgnc_symbol
  hgnc_symbol: PDGFRB
  entrez: '5159'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: GRB2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: NRAS
  symbol: NRAS
  source: hgnc_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: DUSP
  symbol: DUSP
  source: bioentities_symbol
  hgnc_symbol: DUSP6
  entrez: '1848'
- word: PGC1a
  symbol: PGC-1alpha
  source: hgnc_alias_symbol
  hgnc_symbol: PPARGC1A
  entrez: '10891'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PI-3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI-3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: CRAF
  symbol: c-Raf
  source: hgnc_alias_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: PI-3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: MITF
  symbol: MITF
  source: hgnc_symbol
  hgnc_symbol: MITF
  entrez: '4286'
- word: DUSP
  symbol: DUSP
  source: bioentities_symbol
  hgnc_symbol: DUSP3
  entrez: '1845'
- word: DUSP
  symbol: DUSP
  source: bioentities_symbol
  hgnc_symbol: DUSP4
  entrez: '1846'
- word: DUSP
  symbol: DUSP
  source: bioentities_symbol
  hgnc_symbol: DUSP5
  entrez: '1847'
- word: SPRY
  symbol: SPRY
  source: bioentities_symbol
  hgnc_symbol: SPRY3
  entrez: '10251'
- word: SPRY
  symbol: SPRY
  source: bioentities_symbol
  hgnc_symbol: SPRY1
  entrez: '10252'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: ERBB3
  symbol: ERBB3
  source: hgnc_symbol
  hgnc_symbol: ERBB3
  entrez: '2065'
- word: DUSP
  symbol: DUSP
  source: bioentities_symbol
  hgnc_symbol: DUSP1
  entrez: '1843'
- word: SPRY
  symbol: SPRY
  source: bioentities_symbol
  hgnc_symbol: SPRY4
  entrez: '81848'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: PI-3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: ERBB2
  symbol: ERBB2
  source: hgnc_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: JARID1B
  symbol: JARID1B
  source: hgnc_prev_symbol
  hgnc_symbol: KDM5B
  entrez: '10765'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: PI-3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI-3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: SPRY
  symbol: SPRY
  source: bioentities_symbol
  hgnc_symbol: SPRY2
  entrez: '10253'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC4212018__F1
redirect_from: /figures/PMC4212018__F1
figtype: Figure
---
